MoneyWorks4Me

Syncom Formulations (India) submits newspaper clippings

11 Feb 2025 Evaluate

Pursuant to Regulation 30 read with Schedule III Part A(A) and in compliance of Regulation 47(1)(b) of SEBI (LODR) Regulations, 2015 regarding extract of Un-Audited Standalone and Consolidated Quarter and Nine months ended on 31st December, 2024 was also approved by the Audit Committee and Board of Directors at their meeting held on Monday, 10th February, 2025. Syncom Formulations (India) has informed that it enclosed the newspaper advertisement published on 11.02.2025 in Free Press Journal English edition and Marathi (vernacular) Newspaper. The advertisement includes a Quick Response code and the weblink to access complete financial results for the said period. The above information is also available on the website of the Company. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..